Related Experiment Video
Updated: May 12, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Glycopeptide minimum inhibitory concentration creep among meticillin-resistant Staphylococcus aureus from 2006-2011
Chao Zhuo1, Ying-chun Xu, Shu-nian Xiao
1State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical College, Guangzhou, China. chao_sheep@263.net
Abstract:
Vancomycin minimum inhibitory concentration (MIC) creep has recently been demonstrated by many countries but is rarely reported in China. In this study, a total of 1411 meticillin-resistant Staphylococcus aureus (MRSA) isolates were collected from six hospitals in China during the period 2006-2011 and the MICs of vancomycin, teicoplanin and linezolid were determined by broth microdilution according to Clinical and Laboratory Standards Institute (CLSI) guidelines. MIC50 and MIC90 values (MICs required to inhibit the growth of 50% and 90% of organisms, respectively) as well as geometric mean (GM) MICs were calculated for all isolates in each year, and MIC creep for the drugs was evaluated. All of the MRSA isolates were susceptible to vancomycin and linezolid. Overall, the vancomycin GM MIC of MRSA isolates was 0.906, 0.952, 0.956, 0.947, 1.013 and 1.040 mg/L, with a significantly increasing trend over the years (P<0.001). Percentages of MRSA isolates with a vancomycin MIC above 1 μg/mL (2 μg/mL≥MIC>1 μg/mL) were 26.0%, 23.5%, 21.6%, 27.8%, 30.6% and 42.8% from 2006-2011, respectively, and increased over time (P<0.005). The teicoplanin GM MIC increased rapidly from 0.749 mg/L in 2008 to 0.973 mg/L in 2011, and ca. 5% of isolates were resistant to teicoplanin in the period according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria. MIC shifts were not found for linezolid (P>0.05). In conclusion, a tendency towards decreasing susceptibility to glycopeptides in MRSA has emerged in China.
Insights
Vancomycin resistance in MRSA is increasing in China, with higher minimum inhibitory concentrations (MICs) observed over time. This trend suggests a growing challenge in treating MRSA infections with standard glycopeptide antibiotics.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Vancomycin minimum inhibitory concentration (MIC) creep, indicating reduced susceptibility, is a global concern for methicillin-resistant Staphylococcus aureus (MRSA).
- Data on vancomycin MIC creep in China has been limited, necessitating local surveillance.
Purpose of the Study:
- To investigate the trends in vancomycin, teicoplanin, and linezolid MICs among MRSA isolates in China from 2006 to 2011.
- To evaluate the emergence of vancomycin MIC creep and assess susceptibility patterns to other antibiotics.
Main Methods:
- Analysis of 1411 MRSA isolates collected from six Chinese hospitals between 2006 and 2011.
- Determination of vancomycin, teicoplanin, and linezolid MICs using broth microdilution according to CLSI guidelines.
- Calculation of MIC50, MIC90, and geometric mean (GM) MICs annually to evaluate MIC creep.
Main Results:
- A statistically significant increasing trend in vancomycin GM MICs was observed (P<0.001), with values rising from 0.906 mg/L in 2006 to 1.040 mg/L in 2011.
- The percentage of MRSA isolates with vancomycin MICs above 1 μg/mL increased significantly over the study period (P<0.005).
- Teicoplanin GM MICs also showed a rapid increase, and approximately 5% of isolates were resistant according to EUCAST criteria, while linezolid MICs remained stable.
Conclusions:
- A clear tendency towards decreasing susceptibility to glycopeptides, including vancomycin and teicoplanin, has emerged in Chinese MRSA isolates.
- The observed vancomycin MIC creep highlights a potential challenge for effective MRSA treatment in China.
- Continued monitoring of antimicrobial susceptibility is crucial for guiding clinical practice and infection control strategies.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Antimicrobial Effectiveness
Inhibitors of Bacterial Protein Synthesis
Development of Antibiotic Resistance